주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Saturday, Aprill 20, 2024, 00:03
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Samsung Biologics Signs Contract Worth 381.9 Billion Won with UCB for Contract Manufacturing
이미지기사
Healthcare & Bio
Jasmine Choi
03.07 15:47
Pharmaceutical, Biotech Companies Gather in San Francisco
이미지기사
Healthcare & Bio
비지니스코리아 기자
01.05 10:57
Dong-A ST Signs License-in Agreement on Cenobamate with SK Biopharmaceuticals
이미지기사
Healthcare & Bio
Michael Herh
01.04 17:41
SK Life Science to Host Symposium and Present New Data at the AES 2023 Annual Meeting
이미지기사
Healthcare & Bio
Jasmine Choi
2023.11.30 09:41
SK Inc.’s board of directors declares an interim dividend of KRW 1,500 per share
이미지기사
ESG
Jung Min-hee
2023.07.26 17:27
June data confirms favorable XCopri prescription growth
이미지기사
Finance
Pyeongkuk Park
2023.07.10 17:40
Cenobamate by SK biopharmaceuticals Receives Market Approval in Canada
이미지기사
Industries
Jasmine Choi
2023.06.16 10:50
Third-gen epilepsy treatment market (US) sees highest overall growth since Covid-19
이미지기사
Finance
Pyeongkuk Park
2023.04.19 14:51
South Korean New Drugs Enjoying Sales Growth in the U.S.
이미지기사
Lifestyle
Choi Moon-hee
2023.02.27 11:50
SK Biopharm: Time to Mount Structural Upturn
이미지기사
Finance
Park Pyeong-kuk
2023.02.10 14:52
SK Biopharm: Achieved Sound Earnings on Recognition of Licensing-out Fee in Latin America
이미지기사
Finance
Park Pyeong-kuk
2022.11.11 14:41
SK Biopharm: Three Years after Launch, Time to Enjoy Direct Sales for Xcopri
이미지기사
Finance
Park Pyeong-kuk
2022.06.21 10:44
SK Group to Invest KRW247tn in Key Growth Areas for Five Years
이미지기사
ESG
Jung Min-hee
2022.05.27 10:40
SK Biopharmaceuticals Licenses out Epilepsy Treatment Technology to Endo International
이미지기사
Lifestyle
Choi Moon-hee
2021.12.24 17:01
KT Makes Equity Investment in NeuroSigma, U.S. Electronic Drug Developer
이미지기사
ICT
Kim Eun-jin
2021.12.10 11:14
SK Biopharmaceuticals Sued by Its European Partner
이미지기사
Lifestyle
Choi Moon-hee
2021.11.17 16:13
Cerecin Raises US$40mn Series II and IIA Financing
이미지기사
Finance
Yoon Young-sil
2021.10.19 11:37
U.S. FDA to Carry Out Due Diligence on Hanmi Pharmaceutical's Rolontis Production Facilities in May
이미지기사
Lifestyle
Choi Moon-hee
2021.05.07 14:15
SK Biopharm Licenses out New Drug Technology to Japan
이미지기사
Lifestyle
Choi Moon-hee
2020.10.14 14:13
SK Biopharm to Conduct Clinical Trials of Epilepsy Treatment Cenobamate in Asia
이미지기사
Lifestyle
Choi Moon-hee
2020.09.11 15:55
처음
1
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기